DYNALYNK PHARMA PTE. LTD.
UEN: 199902310E
DYNALYNK PHARMA PTE. LTD.(199902310E) is a Singapore business with registered business address at 48 LORONG 21 GEYLANG, 3-1, GREATLAND BUILDING, Singapore 388464. They specialise in the area of MANUFACTURE OF PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR HUMAN USE (EG TABLETED PRODUCTS) and WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT.
| Company Name | DYNALYNK PHARMA PTE. LTD. |
| Unique Entity Number | 199902310E |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 03 May 1999 |
| Address |
48 LORONG 21 GEYLANG #3-1 GREATLAND BUILDING Singapore 388464 |
| Products / Services |
MANUFACTURE OF PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR HUMAN USE (EG TABLETED PRODUCTS) WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT |
| Number of Officers | 5 |
| Paid Up Capital | SGD 4337500 |
Breaking! Business News
New Cryptocurrency Mining Era with ASICLineNew Cryptocurrency Mining Era with ASICLine GlobeNewswire October 26, 20...
Read More
Aptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and DevelopmentAptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and Deve...
Read More
Taconic Biosciences launches critical model for COVID-19 researchTaconic Biosciences launches critical model for COVID-19 research Immediate availability of ...
Read More
Zoom Launches End-to-End Encryption for Free and Paid Users GloballyZoom Launches End-to-End Encryption for Free and Paid Users Globally New Encryption Feature ...
Read More
Bombardier Announces Closing Date, Amended Terms for Sale of Aerostructures Business to Spirit AeroSystems Holding, Inc.Bombardier Announces Closing Date, Amended Terms for Sale of Aerostructures Business to Spirit AeroS...
Read More
A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine StormsA Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-1...
Read More
Private 5G Innovator Celona Closes Series B Round Led by NTTVC and Qualcomm Ventures to Expand and Fuel Private Mobile Network GrowthPrivate 5G Innovator Celona Closes Series B Round Led by NTTVC and Qualcomm Ventures to Expand and F...
Read More
Philips empowers medical image access for over 5,000 clinicians in the Region of Southern DenmarkPhilips empowers medical image access for over 5,000 clinicians in the Region of Southern Denmark ...
Read More